FDA and NIH Collaborate on New Memorandum of Understanding for Toxicity Research

Summary

The Food and Drug Administration (FDA) and the National Institutes of Health (NIH) have signed a new Memorandum of Understanding (MOU) to strengthen collaborations on toxicology research, utilizing expertise from multiple agencies, including the Environmental Protection Agency (EPA) and the National Human Genome Research Institute (NHGRI).